Buprenorphine Update: Practical Applications & State of the Art Innovations in OBOT - October



This virtual buprenorphine update has been developed for these reasons:

  1. There are challenging clinical issues involved: stabilization vs maintenance doses; treating opiate addicted patients who have concomitant chronic intractable pain; treating opiate addicted patients with co-morbid depressive or anxiety disorders or sleep disturbances; and management of opiate medication side-effects
  2. There are unique ethical issues involved: patient safety vs minimization of disruption to daily life and obligation to the individual patient vs obligation to the community well-being
  3. There are unique Patient-Doctor and Patient-Treatment Program issues: staff splitting by patients; appropriately supervising toxicology testing while maintaining dignity; patient confidentiality concerns vs the need to have data from other providers regarding patient stability; and issues about dose adjustment, level of supervision and documentation
  4. There are rapidly changing expectations and concerns from regulatory agencies that must be understood and integrated into an evolving standard of care, and documented during increasingly frequent site visits and chart audits
On the agenda:
  • Overview of the Drug Addicted Brain
  • Federal Law (Data 2000) and Medical Board Rules Regarding Buprenorphine Office-Based Opioid Treatment (OBOT)
  • Emerging Pharmacology of Buprenorphine
  • Buprenorphine Delivery Systems
  • Getting Started with Prescribing Buprenorphine
  • Maintaining Medical Documentation in OBOT
  • Lunch Session: Difficult Conversations When Providing OBOT
  • Diagnosis and Management of Anxiety n the OBOT Patient
  • Buprenorphine, Chronic Pain and a Patient with Opioid Use
  • Minimizing Diversion When Prescribing Buprenorphine
  • Approaches to Tapering
  • Case Studies in OBOT
8 AMA PRA Category 1 Credits™

8 ABIM MOC points


October 12, 2022


Virtual Conference




cwru.cloud-cme.com/course/courseoverview?P=5& EID=49870/